Latest filing published 05 Jul 2012 for RenovaCare, Inc., €28k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kalen Capital Corp: trading record in brief
Kalen Capital Corp is a declared insider at 2 companies; the most frequent names are Alliqua BioMedical, Inc. and RenovaCare, Inc. We count 2 filings; the first trade dates from 28 March 2012 and the latest from 3 July 2012.
Both buying and selling appear: 1 purchase worth €28k, against 1 sale worth €722k. Netting one side against the other leaves €694k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 5 July 2012, reports an open-market purchase of €28k in RenovaCare, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kalen Capital Corp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500,000 shares@ US$0.01Common SharesSEC:0001448961-12-000002:0Canonical exit: 1 Oct 2012 (T+90)
- 24,057,980 shares@ US$0.04Common sharesSEC:0001448961-12-000001:0
2 of 2 declarations